Literatur
Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653 (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group)
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care 39:686–693
Zwiener I, Blettner M, Hommel G (2011) Survival analysis—part 15 of a series on evaluation of scientific publications. Dtsch Arztebl Int 108(10):163–139
Riddle MC, Gerstein HC (2019) The cardiovascular legacy of good glycemic control: clues about mediators from the DCCT/EDIC study. Diabetes Care 42:1159–1161
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Jecht gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Jecht, M. Bedeutung der Hyperglykämie für das Risiko von CVD-Ergebnissen bei Typ-1-Diabetes. Diabetologe 15, 587–588 (2019). https://doi.org/10.1007/s11428-019-00523-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-019-00523-8